For the first time in its 75-year history, the maximum cost of general scripts under the Pharmaceutical Benefits Scheme (PBS) will fall. Under a Bill
Monash University researchers have conducted a review into the prevalence of depression and anxiety of people with cystic fibrosis, a life-limiting genetic disease associated with
From 1 December 2021, Australians with acute myeloid leukaemia (AML) will have access to a new treatment option on the Pharmaceutical Benefits Scheme (PBS). The